NICE chief: Approval changes 'won't increase NHS drugs bill'

By Nick Renaud-Komiya2014-03-27T09:37:00

The head of the National Institute of Health and Care Excellence has suggested the NHS will not pay more overall for branded pharmaceuticals in future as a result of proposed changes to the way the organisation assesses the value of new drugs.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here